Ignite Creation Date:
2025-12-24 @ 5:25 PM
Ignite Modification Date:
2025-12-26 @ 7:22 AM
Study NCT ID:
NCT04061850
Status:
COMPLETED
Last Update Posted:
2020-10-22
First Post:
2019-08-14
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Ibrutinib for Relapsed or Refractory Mantle Cell Lymphoma
Sponsor:
Samsung Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-07-01
Start Date Type:
ACTUAL
Primary Completion Date:
2020-03-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-08-31
Completion Date Type:
ACTUAL
First Submit Date:
2019-08-14
First Submit QC Date:
None
Study First Post Date:
2019-08-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-10-21
Last Update Post Date:
2020-10-22
Last Update Post Date Type:
ACTUAL